Ergoteles’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,019	Closed	-$190K	–	1755
2022 Q4	$190K	Buy	+14,019	New	+$190K	0.01%	1090
2022 Q3	–	Sell	-18,807	Closed	-$229K	–	1990
2022 Q2	$229K	Buy	+18,807	New	+$229K	0.01%	1251